Accelerating Preclinical Genomics Development with Inotiv Services

Precision-Driven Preclinical Solutions to Advance Your Genomics Innovations

At Inotiv, we understand the complexities and potential of genomics in reshaping the future of medicine. Our specialized Contract Research Organization (CRO) services are designed to support every phase of your preclinical cell and gene therapy (CGT) development—from target discovery to IND-enabling studies.

With decades of experience, cutting-edge technologies, and a commitment to scientific excellence, Inotiv is your trusted partner in bringing CGT breakthroughs to life.

Contact us today to schedule a consultation with our genomics team and discover how we can support your next breakthrough.

Our Genomics CRO Capabilities

Genomics Biomarker Discovery

Advanced sequencing technologies (RNA-seq, WGS, WES)
Bioinformatics analysis and interpretation
Predictive biomarker identification for efficacy and safety

Biodistribution, Persistence, Gene Expression & Vector Integration Analysis

Biodistribution and vector shedding assessment by qPCR/qRT-PCR
Target gene expression by qRT-PCR
Alu PCR for cell biodistribution, quantification and persistence

Gene Editing & Model Development

CRISPR/Cas9-generated in vivo models
Transgenic and knockout mouse models
Rapid model creation for disease relevance and drug targeting

Functional Genomics Studies

Gene expression profiling
Pathway analysis and target validation
Custom assays for mechanistic insight

Preclinical Safety & Toxicology

GLP-compliant safety studies
Tissue-specific genomic impact evaluations

Bioinformatics & Data Integration

Multi-omics data analysis (genomics, transcriptomics, proteomics)
AI-enhanced predictive modeling
Custom dashboards for data visualization

Why Partner with Inotiv?

Scientific Rigor: Our genomics experts collaborate closely with your team to design studies that align with regulatory expectations and scientific goals.
Custom Solutions: Tailored approaches for rare diseases, oncology, gene therapies, and more.
Integrated Workflow: Streamlined project management from in vitro proof-of-concept to IND submission.
Speed & Scale: Accelerate your timelines with our responsive service model and scalable lab infrastructure.

Let’s Power Genomics Discovery Together

Whether you're targeting rare genetic diseases or developing personalized therapies, Inotiv's preclinical genomics services provide the insights and support you need to move forward with confidence.

General Toxicology General Toxicology Inotiv offers a range of general toxicology studies to evaluate the safety of drugs, medical devices, and other chemicals. We design and conduct studies according to international regulations and our toxicology expertise can help assess potential risks and ensure the safety of your product.

Surgical Models and Medical Device Testing Surgical Models and Medical Device Testing

Our nonclinical testing services feature veterinary surgeons, state-of-the-art imaging, and a commitment to excellence to advance your medical device.

Histology Histology

Our industry-leading histology laboratories support your discovery and nonclinical development projects with a wide range of services. From tissue processing to digital analysis, our team delivers the quality you expect.

Drug Metabolism and Pharmacokinetics (DMPK) Drug Metabolism and Pharmacokinetics (DMPK) Whatever you need, from method development to metabolite ID, our phase-appropriate bioanalytical services help you analyze, answer, and advance.

Consulting Consulting Our experts deliver the insights you deserve to get the answers you need, whether in DMPK data analysis, biomarker analysis, or bioequivalence studies.

Precision-Driven Preclinical Solutions to Advance Your Genomics Innovations

Our Genomics CRO Capabilities

Why Partner with Inotiv?

Let’s Power Genomics Discovery Together

Subscribe to updates from Inotiv